ABOUT STROKE
Print version was published: EXPERIMENTAL & CLINICAL MEDICINE N 4 (2016)
DOI:
https://doi.org/10.52340/jecm.2021.615Abstract
250 patients with cerebral blood flow disorder were tested at Adjarian Oncocenter. Among them 114 female and 86 male. Patients were grouped according to scale of stroke , developed by National health Institute. Plasminogen Activator ( t-PA) was most effective during acute stroke . Hospitalization of patient should not be oriented only for treatment of stroke but also about identifying Risk factors. Multidisciplinary (doctors, physiotherapists, occupational therapist , psychologists, specialized nurses and social workers ) group should be involved in rehabilitation process, which is the key for managing stroke patients.
Downloads
References
Asaithambi G, Tong X, George MG, Tsai AW, Peacock JM, Luepker RV, Lakshminarayan K. Acute stroke reperfusion therapy trends in the expanded treatment window era. J Stroke Cerebrovasc Dis. 2014 Oct;23(9):2316-21. doi: 10.1016/j.jstrokecerebrovasdis.2014.04.023
Greer S, Schieb L, Ritchey M, George M, Casper M. County Health Factors Associated with Avoidable Deaths from Cardiovascular Disease in the United States, 2006–2010 [PDF-3M]. Public Health Reports. 2016 May-June;131:438-448.
Tong X, George MG, Yang Q, Gillespie C. Predictors of in-hospital death and symptomatic intracranial hemorrhage in patients with acute ischemic stroke treated with thrombolytic therapy: Paul Coverdell Acute Stroke Registry 2008-2012. Int J Stroke. 2014 Aug;9(6):728-734.
Joo H, George, MG, Fang, J, Wang, G. A Literature Review of Indirect Costs Associated with Stroke. J Stroke Cerebrovasc Dis. 2014 June;23(7):1753-63. doi:10.1016/j.jstrokecerebrovasdis.2014.02.017.
Downloads
Published
How to Cite
Issue
Section
